共 50 条
Impact of Percutaneous Coronary Intervention on Outcomes in Patients With Heart Failure JACC State-of-the-Art Review
被引:32
|作者:
Parikh, Puja B.
[1
]
Bhatt, Deepak L.
[2
,3
]
Bhasin, Varun
[1
]
Anker, Stefan D.
[4
,5
,6
]
Skopicki, Hal A.
[1
]
Claessen, Bimmer E.
[7
]
Fonarow, Gregg C.
[8
]
Hernandez, Adrian F.
[9
,10
]
Mehran, Roxana
[11
]
Petrie, Mark C.
[12
]
Butler, Javed
[13
]
机构:
[1] Stony Brook Renaissance Sch Med, Dept Med, Stony Brook, NY USA
[2] Brigham & Womens Hosp Heart & Vasc Ctr, Dept Med, Boston, MA USA
[3] Harvard Med Sch, Boston, MA 02115 USA
[4] Berlin Inst Hlth Ctr Regenerat Therapies BCRT, Berlin, Germany
[5] Dept Cardiol CVK, Berlin, Germany
[6] Charite, Partner Site Berlin, German Ctr Cardiovasc Res DZHK, Berlin, Germany
[7] Univ Amsterdam, Dept Cardiol, Med Ctr, Amsterdam, Netherlands
[8] Ahmanson UCLA Cardiomyopathy Ctr, Ronald Reagan UCLA Med Ctr, Los Angeles, CA USA
[9] Duke Univ, Duke Clin Res Inst, Sch Med, Durham, NC USA
[10] Duke Univ, Dept Med, Sch Med, Durham, NC USA
[11] Mt Sinai Hosp, Icahn Sch Med, New York, NY USA
[12] Univ Glasgow, BHF Cardiovasc Res Ctr, Glasgow, Lanark, Scotland
[13] Univ Mississippi, Dept Med, Jackson, MS 39216 USA
基金:
美国国家卫生研究院;
关键词:
KEY WORDS coronary artery disease;
coronary revascularization;
ejection fraction;
heart failure;
percutaneous coronary intervention;
ACUTE MYOCARDIAL-INFARCTION;
VENTRICULAR EJECTION FRACTION;
ELUTING STENT IMPLANTATION;
CHRONIC TOTAL OCCLUSIONS;
LONG-TERM OUTCOMES;
INTRAAORTIC BALLOON COUNTERPULSATION;
RANDOMIZED CLINICAL-TRIAL;
FLOW RESERVE;
CARDIOGENIC-SHOCK;
BYPASS-SURGERY;
D O I:
10.1016/j.jacc.2021.03.310
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
Coronary artery disease (CAD) is highly prevalent in patients with heart failure (HF) and accounts for nearly two-thirds of cases. The use of percutaneous coronary intervention (PCI) in HF patients with CAD has markedly increased and has been suggested to be associated with improved outcomes in numerous observational studies. Randomized data comparing the impact of PCI with that of coronary artery bypass graft (CABG) or contemporary guideline-directed medical therapy alone on clinical outcomes and myocardial recovery in patients with HF are lacking. The purpose of this review is to describe the available evidence regarding the impact of PCI in acute HF (in the presence and absence of an acute coronary syndrome), chronic HF with reduced ejection fraction, and HF with preserved ejection fraction. Adequately-powered randomized clinical trials examining the outcomes with PCI in these distinct HF populations are warranted. (J Am Coll Cardiol 2021;77:2432-47) (c) 2021 by the American College of Cardiology Foundation.
引用
收藏
页码:2432 / 2447
页数:16
相关论文